ArticleLasers in medical science2026
Removal of radiation-related tattoos among breast cancer survivors using a 20-nanosecond Q-switched Ruby laser.
Article in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPermanent dark ink tattoos for radiotherapy (radiation-related tattoos) play a critical role in breast cancer management by ensuring accurate field localization and consistent patient positioning. While effective, these markings persist permanently and may negatively impact body image and quality of life. Laser tattoo removal using selective photothermolysis is the standard of care for tattoo removal, with the 20-nanosecond Q-switched ruby laser (QSRL) particularly suited for targeting dark dermal pigment. We evaluated the safety and efficacy of QSRL for the removal of radiation-related tattoos in breast cancer survivors.
methodsA prospective, single-center interventional study of female breast cancer survivors with radiation-related tattoos. Eligible participants underwent up to 6 QSRL treatment sessions. Outcomes were assessed by 2 independent dermatologists through blinded evaluation of pre- and post-treatment photographs using the Global Aesthetic Improvement Scale (GAIS), patient satisfaction scores, and body-image questionnaires. Adverse effects were documented as well.
resultsSeven patients were included with a total of 23 tattoos. Significant improvement or complete resolution (average GAIS ≥ 3) was noted in 91% of treated tattoos, with strong inter-rater agreement (87%). Treatment was well-tolerated, with mild-to-moderate, short-lived pain during the procedure and minimal downtime. Patient satisfaction was high and no adverse events were reported.
conclusionQSRL is a safe, effective, and well-tolerated modality for removing radiation-related tattoos in breast cancer survivors and may represent a valuable component of comprehensive post-treatment care for eligible patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.